Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), bought 20,144 shares at $7.20 ($145K) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Open-market purchase of $145k VERA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.20 | 10,072 | $73K | 50.0% |
| 2 | $7.20 | 10,072 | $73K | 50.0% |
| Total | $7.20 avg | 20,144 | $145K | 100% |
| Filing → |
| VERA | SELL | 2024-09-20 | $1.3M | — | Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |